Dermapharm Holding SE banner

Dermapharm Holding SE
OTC:DMPHF

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
OTC:DMPHF
Watchlist
Price: 39.56 USD
Market Cap: $2.1B

Relative Value

The Relative Value of one DMPHF stock under the Base Case scenario is hidden USD. Compared to the current market price of 39.56 USD, Dermapharm Holding SE is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DMPHF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

DMPHF Competitors Multiples
Dermapharm Holding SE Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Dermapharm Holding SE
OTC:DMPHF
2B USD 1.7 17.5 9.2 12.8
US
Eli Lilly and Co
NYSE:LLY
986.4B USD 15.1 47.7 32.1 34.2
US
Johnson & Johnson
NYSE:JNJ
586.1B USD 6.2 21.9 15.2 18.6
CH
Roche Holding AG
SIX:ROG
287.6B CHF 4.7 30.6 12.9 15
UK
AstraZeneca PLC
LSE:AZN
233.4B GBP 5.4 31.2 17.2 24.2
CH
Novartis AG
SIX:NOVN
241B CHF 5.5 22.2 13.7 17.6
US
Merck & Co Inc
NYSE:MRK
301.2B USD 4.6 16.5 10.3 12.1
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.4 13.3 9.7 11.4
US
Pfizer Inc
NYSE:PFE
157.3B USD 2.5 20.2 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
123.4B USD 2.6 17.5 6.8 8.8
P/E Multiple
Earnings Growth PEG
DE
Dermapharm Holding SE
OTC:DMPHF
Average P/E: 23.8
17.5
9%
1.9
US
Eli Lilly and Co
NYSE:LLY
47.7
28%
1.7
US
Johnson & Johnson
NYSE:JNJ
21.9
7%
3.1
CH
Roche Holding AG
SIX:ROG
30.6
29%
1.1
UK
AstraZeneca PLC
LSE:AZN
31.2
26%
1.2
CH
Novartis AG
SIX:NOVN
22.2
15%
1.5
US
Merck & Co Inc
NYSE:MRK
16.5
14%
1.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
13.3
7%
1.9
US
Pfizer Inc
NYSE:PFE
20.2
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.5
17%
1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DE
Dermapharm Holding SE
OTC:DMPHF
Average EV/EBITDA: 42.5
9.2
5%
1.8
US
Eli Lilly and Co
NYSE:LLY
32.1
18%
1.8
US
Johnson & Johnson
NYSE:JNJ
15.2
2%
7.6
CH
Roche Holding AG
SIX:ROG
12.9
5%
2.6
UK
AstraZeneca PLC
LSE:AZN
17.2
11%
1.6
CH
Novartis AG
SIX:NOVN
13.7
9%
1.5
US
Merck & Co Inc
NYSE:MRK
10.3
7%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
9.7
7%
1.4
US
Pfizer Inc
NYSE:PFE
7.5
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
6.8
-13%
N/A